News

Eli Lilly and Company (LLY): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.
New York Post10d
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic
Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...
Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
Yahoo10d
Eli Lilly's new GLP-1 weight loss pill showed success in clinical trial
Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes management results when compared to the pill’s injectable counterparts. About 1 in 8 adults in the U.S. has taken ...
The Motley Fool4d
Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug
Eli Lilly's oral GLP-1 medicine aced a phase 3 study. It should become a new growth driver for the company. There are other reasons to invest in the pharmaceutical leader. Zepbound's prospects ...